$Oscar Health, Inc.(OSCR)$ Gains +2.32%: Health Insurer Rebounds from Support, Eyes $15.69 Target 🩺The stock rebounded alongside a broader tech sector rally. 📊 Investor focus remains on the company's upcoming quarterly earnings (expected 2026-02-10), with market consensus anticipating +26.23% revenue growth but a deeper adjusted EPS loss. Analyst Targets
🎯 13 analysts have an average price target of $15.69 (upside ~14.5%). Sentiment is mixed with 3 Buy, 6 Hold, 2 Underperform, and 1 Sell ratings.
Weekly Outlook
Expect consolidation between $13.22 and $14.85 in the near term. A decisive break above $14.85 could target the $15.50-$16.00 zone. A failure to hold $13.22 may lead to a retest of the $13.00 support.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
